JGCM
GILD icon

Joseph Group Capital Management’s Gilead Sciences GILD Stock Holding History

Joseph Group Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.3K Buy
327
+75
+30% +$9.88K 0.01% 149
2026
Q1 		$35.1K Buy
252
+83
+49% +$11.6K 0.01% 125
2025
Q4 		$20.7K Buy
+169
New +$20.5K 0.01% 129

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Joseph Group Capital Management's GILD Position: Q2 2026 in Review

Joseph Group Capital Management increased its Gilead Sciences (GILD) stake by 30% in Q2 2026, buying an estimated $9.88K and bringing the position to 327 shares worth $41.3K. The position accounts for 0.01% of the portfolio, ranked #149.

Joseph Group Capital Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Joseph Group Capital Management held 327 shares of Gilead Sciences worth $41.3K as of Q2 2026.
  • Joseph Group Capital Management bought 75 Gilead Sciences shares in Q2 2026, an estimated $9.88K.
  • Gilead Sciences made up 0.01% of Joseph Group Capital Management's portfolio in Q2 2026, its #149 holding.
  • Joseph Group Capital Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Joseph Group Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.